CDKI-IN-1

• Description :

  CDKI-IN-1 (Compound SNX12) is a cyclin-dependent kinase inhibitor (CDKI) inhibitor that can be used for research into degenerative diseases of the central nervous system[1].

• UNSPSC :

  12352005

• Target :

  CDK

• Related Pathways :

  Cell Cycle/DNA Damage

• Field of Research :

  Neurological Disease

• Smiles :

  C=CCN1C2=C(C=CC=C2)N=C1/C=C/C3=CC=CO3.Cl

• Molecular Formula :

  C16H15ClN2O

• Molecular Weight :

  286.76

• References & Citations :

  [1]Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent, US20090281129. 2009-11-12.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1185726-51-5]